A share price of Abbvie Inc [ABBV] is currently trading at $225.17, up 2.95%. An important factor to consider is whether the stock is rising or falling in short-term value. The ABBV shares have gain 4.30% over the last week, with a monthly amount drifted -2.23%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on November 04, 2025, when DZ Bank downgraded its rating to a Hold but kept the price target unchanged to $237 for it. Previously, Erste Group downgraded its rating to Hold on October 14, 2025. On October 01, 2025, downgrade downgraded it’s rating to Hold. Berenberg upgraded its rating to a Buy but stick to its price target of $270 on September 17, 2025. Daiwa Securities upgraded its rating to Outperform for this stock on August 07, 2025, but kept the price target unchanged to $214. In a note dated May 14, 2025, Citigroup downgraded a Neutral rating on this stock but restated the target price of $205.
Abbvie Inc experienced fluctuations in its stock price throughout the past year between $163.81 and $244.81. Currently, Wall Street analysts expect the stock to reach $252.17 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $225.17 at the most recent close of the market. An investor can expect a potential return of 11.99% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Trailing Twelve Months sales for Abbvie Inc [NYSE:ABBV] were 59.64B which represents 9.10% growth. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 4.99 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -26.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 220.97 points at the first support level, and at 216.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 227.39, and for the 2nd resistance point, it is at 229.62.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abbvie Inc [NYSE:ABBV] is 0.72. On the other hand, the Quick Ratio is 0.60, and the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 6.67 and price to earnings (TTM) ratio is 169.90.
Transactions by insiders
Recent insider trading involved Richard A. Gonzalez, Former Director, that happened on Aug 22 ’25 when 62755.0 shares were purchased. Former Director, Richard A. Gonzalez completed a deal on Aug 21 ’25 to buy 90000.0 shares. Meanwhile, EVP, CHIEF OPERATIONS OFFICER SALEKI-GERHARDT AZITA sold 42370.0 shares on Aug 12 ’25.
